Neuraminidase Inhibitors Drug Market Size

Neuraminidase Inhibitors Drug Market size was over USD 98.04 billion in 2023 and is anticipated to cross USD 233.41 billion by 2036, witnessing more than 6.9% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of neuraminidase inhibitors drug is estimated at USD 103.45 billion.

This growth can be witnessed as a result of an increasing prevalence of influenza globally. Further, the advancement in the market and development of the drug is being focused upon by the companies. This will boost the market as well.